| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $79.4M | +4.9% | +9.0% |
| Cost of Revenue | $34.6M | +2.4% | +5.2% |
| Gross Profit | $44.8M | +7.0% | +12.2% |
| R&D Expense | $7.8M | +21.1% | +20.7% |
| SG&A Expense | $10.2M | -19.1% | -2.3% |
| Operating Income | -$6.1M | +42.5% | +44.8% |
| Pre-tax Income | -$6.4M | +41.4% | +41.4% |
| Income Tax | -$5K | -107.7% | +95.5% |
| Net Income | -$6.3M | +41.8% | +40.9% |
| EPS (Basic) | -$0.15 | +42.3% | +42.3% |
| EPS (Diluted) | -$0.15 | +42.3% | +42.3% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.6M | +7.4% | -23.0% |
| Accounts Receivable | $44.4M | +4.2% | +3.0% |
| Inventory | $65.6M | +5.3% | -0.5% |
| Current Assets | $161.3M | +3.0% | -8.0% |
| Total Assets | $269.7M | +1.5% | -7.5% |
| Current Liabilities | $72.0M | +5.4% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.3M | +29.3% | — |
| Capital Expenditures | $1.2M | +57.7% | — |
| Investing Cash Flow | -$3.2M | -104.5% | — |
| Financing Cash Flow | $51K | -64.3% | — |
| Free Cash Flow | -$12.4M | +25.5% | — |
| -18.8% |
| Total Liabilities | $93.3M | +7.6% | -10.9% |
| Stockholders' Equity | $176.3M | -1.4% | -5.6% |